Sign in

FinnGen

@finngen.bsky.social
370 followers 147 following 127 posts

A forerunner in the global landscape of genomics research projects. The study has collected and analysed genome and health data from >500,000 Finnish biobank donors to understand the genetic basis of diseases. www.finngen.fi

PostsRepliesMedia
FinnGen @finngen.bsky.social · 01/10/2026
Using data from more than 1,100 Finnish blood donors participating in FinnGen, @masakanai.bsky.social and colleagues have created an atlas of over 10 million immune cells that links disease-associated genetic variants to the genes they control. The findings were just published in @nature.com.
Graphic announcing a new publication in Nature. The article is titled “Population-scale immune multiome atlas reveals regulatory disease mechanisms.” The publication date is 30 September 2026. The FinnGen logo appears on the right side of the graphic.
142
Reposted by FinnGen
Masahiro Kanai @masakanai.bsky.social · 30/09/2026
Our single-nucleus immune multiome atlas is now out in @nature.com! 🧬 10M PBMCs from 1,108 @finngen.bsky.social donors recruited by Finnish Blood Service, profiled at @broadinstitute.org with chromatin accessibility and gene expression in the same nuclei, to trace how disease variants act 🧵👇
13317
FinnGen @finngen.bsky.social · 06/08/2026
FinnGen-tutkimusaineistoa on hyödynnetty ensimmäisessä laajassa fibromyalgiaan keskittyvässä geenitutkimuksessa. Tulokset osoittavat, että sairauden taustalla on keskushermoston poikkeava tapa käsitellä kipua, ja auttavat näin ymmärtämään fibromyalgian syntyä: 🔗 www.finngen.fi/fi/edistysas...
finngen.fi
Edistysaskel kipututkimuksessa: geenit osoittavat keskushermoston merkityksen fibromyalgian taustalla | FinnGen
Suuri kansainvälinen tutkimus on löytänyt uusia fibromyalgialle altistavia geneettisiä riskitekijöitä. Löydös auttaa ymmärtämään fibromyalgian syntyä ja voi vauhdittaa uusien hoitojen kehittämistä.
000
FinnGen @finngen.bsky.social · 09/07/2026
Pregnancy-related liver disease remains poorly understood, but genetics is helping to change that. A recent study identified novel genetic factors associated with intrahepatic cholestasis of pregnancy, providing new insights into the disease mechanisms. Read more: www.tuni.fi/en/tau/news-...
tuni.fi
Large-scale genetic study uncovers new factors associated with a pregnancy-related liver disease | Tampere University
Intrahepatic cholestasis of pregnancy (ICP) is the most common liver condition that occurs during pregnancy and is characterised by a disruption in the normal flow of bile from the liver. A new int...
001
FinnGen @finngen.bsky.social · 06/07/2026
FinnGen-based study by Nina Mars, Joni Turunen and colleagues demonstrates that polygenic risk scores can identify individuals at substantially increased risk of developing glaucoma and those whose disease is likely to progress more rapidly. Read more: www.helsinki.fi/en/news/gene...
helsinki.fi
Genetic information helps predict the onset and progression of glaucoma | University of Helsinki
Polygenic risk scores can identify individuals at substantially increased risk of developing glaucoma and those whose disease is likely to progress more rapidly. A new screening model based on these f...
111
FinnGen @finngen.bsky.social · 18/06/2026
A unique job opportunity to work on some of the most exciting genomic datasets in the world!
068
FinnGen @finngen.bsky.social · 17/06/2026
FinnGen-konsortioon kuuluvat tutkijat Oulun yliopistosta ovat tunnistaneet kymmeniä uusia geneettisiä riskitekijöitä lannerangan selkäydinkanavan ahtaumalle. Tutkimus auttaa ymmärtämään paremmin tätä yleistä selkäsairautta. Lue lisää @oulu.fi tiedotteesta: www.oulu.fi/fi/uutiset/s...
oulu.fi
Suuri geenitutkimus paljasti uusia riskitekijöitä yleiselle selkäsairaudelle
Tutkijat tunnistivat kymmeniä uusia geneettisiä riskitekijöitä lannerangan selkäydinkanavan ahtaumalle.
010
FinnGen @finngen.bsky.social · 05/06/2026
FinnGen-konsortioon kuuluvia tutkijoita Itä-Suomen yliopistosta on osallistunut kansainväliseen yhteistyötutkimukseen, jossa tunnistettiin yli 90 Alzheimerin taudin riskiin liittyvää geneettistä aluetta. Laaja meta-analyysi tuotti uutta ymmärrystä taudin biologiasta. 🔗 www.uef.fi/fi/artikkeli...
uef.fi
Tutkijat tunnistivat yli 90 geenialuetta, jotka liittyvät Alzheimerin taudin riskiin
Tulokset korostavat immuunijärjestelmän, beeta-amyloidin, tau-proteiinin sekä rasva-aineenvaihdunnan keskeistä roolia Alzheimerin taudissa.
010
FinnGen @finngen.bsky.social · 03/06/2026
We are pleased to announce the release of FinnGen DF13 results! 🧬 While the number of participants remains unchanged, DF13 incorporates updated health register data, increasing the number of cases across most disease endpoints. Browsing & download instructions here: www.finngen.fi/en/access_re...
053
FinnGen @finngen.bsky.social · 21/05/2026
We’re looking for a Project Manager to join our FinnGen team in Helsinki! The role centers on financial management of a major international research collaboration project. If keeping complex projects financially on track are your thing, this might be for you! jobs.helsinki.fi/job/Helsinki...
A recruitment poster for the FinnGen project appears on a light gray background. On the left side is a large stylized DNA-inspired FinnGen logo in purple and gray above the word “FINNGEN” written in large purple capital letters. On the right side, bold black text reads “PROJECT MANAGER,” followed by smaller text that says “FOR THE FINNGEN PROJECT.” Beneath this are the logos for FIMM (Institute for Molecular Medicine Finland, HiLIFE Unit) and the University of Helsinki. At the bottom right, bold black text reads “APPLY BY 5 JUNE.”
030
FinnGen @finngen.bsky.social · 26/03/2026
Two inspiring days at the FinnGen meeting at Novartis, Cambridge! Partners shared latest insights from FinnGen data across diseases & advances in biobank-scale analyses. Just as important were discussions on the future, outlining the next phase of FinnGen. Many thanks to our hosts and participants!
A four-panel collage of the FinnGen F2F meeting. Top left: a room full of attendees seated at tables, watching a presenter speaking in front of a projected slide. Top right: the exterior of a modern glass office  on a clear day. Bottom left: a speaker presenting slides with charts at a podium in a bright conference room. Bottom right: a large audience seated and listening attentively during a presentation, many with laptops open.
030
Reposted by FinnGen
University of Helsinki @helsinki.fi · 27/02/2026
Tutkimuksemme kärjet ovat Tulevaisuuden teknologiat, Oppivat ja muuntuvat yhteiskunnat, Yksilöllinen terveys ja Kestävä planeetta. www.helsinki.fi/fi/uutiset/y...
helsinki.fi
Helsingin yliopisto on tunnistanut neljä tutkimuksen kärkeä – monitieteinen huippututkimus kohtaa aikamme suuret haasteet | Helsingin yliopisto
Helsingin yliopisto on tunnistanut neljä tutkimuksen kärkeä, jotka kokoavat yhteen yliopiston tutkimuksen vahvuudet. Kärjet yhdistävät ihmis-, elämän- ja luonnontieteellistä huippututkimusta ja vastaavat aikamme keskeisiin haasteisiin.
071
FinnGen @finngen.bsky.social · 27/02/2026
Large-scale FinnGen-based study by Reeve et al., just published in Nature Genetics, provides the most detailed genetic map of autoimmune hypothyroidism to date and reveals a surprising inverse relationship between hypothyroidism risk and skin cancer risk. www.broadinstitute.org/news/study-r...
broadinstitute.org
Study reveals genetic balancing act between autoimmunity and cancer risk
Researchers pinpoint genetic factors linked to both higher risk of a common autoimmune disorder and lower cancer risk
196
FinnGen @finngen.bsky.social · 20/02/2026
Tiesitkö, että FinnGen-tutkimuksessa tuotettu genomitieto on palautettu takaisin näytteen toimittaneeseen biopankkiin? Veripalvelun biopankissa on pilotoitu tähän tietoon perustuen hemokromatoosin riskitiedon palauttamista biopankkiin kuuluville verenluovuttajille: www.veripalvelu.fi/verenluovutt...
veripalvelu.fi
Verenluovuttajat saivat ensimmäistä kertaa tietoa perinnöllisestä sairausriskistä
Suomen Punaisen Ristin Veripalvelun biopankista palautettiin tietoa riskistä sairastua hemokromatoosiin eli tautiin, jossa elimistöön kerääntyy liikaa rautaa.
131
FinnGen @finngen.bsky.social · 09/02/2026
The largest genetic study of anxiety disorders to date has identified 58 genetic variants associated with anxiety. The research, published in Nature Genetics, was based on data from >120,000 individuals with anxiety disorders, from various cohorts, including FinnGen. www.nature.com/articles/s41...
A promotional graphic announcing a new scientific publication from FinnGen. The center shows the title page of an article from Nature Genetics titled “Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling”. On top, a blue banner reads “New Publication.” The bottom right features the FinnGen logo—a stylized DNA helix—and the word “FinnGen.” Citation details appear at the bottom of the image.
140
Reposted by FinnGen
BBMRI-ERIC @bbmrieric.bsky.social · 04/02/2026
🌍 On #WorldCancerDay we recognise those in the BBMRI-ERIC community working to advance cancer research. 🔬 In our first post, we looked at EU projects. Let's turn the spotlight on the researchers & biobankers driving cancer innovation - The teams behind the data, discoveries & breakthroughs. 🧵 1/2
241
FinnGen @finngen.bsky.social · 04/02/2026
FinnGenin suomalaisten partnerien edustajat tapasivat eilen Biomedicumissa Helsingissä ja etäyhteyden välityksellä. Kiitos kaikille osallistujille aktiivisuudesta tutkimuksen seuraavan vaiheen suunnittelussa!
Kokoukseen paikan päällä Biomedicumissa osallistuneiden henkilöiden ryhmäkuva.
010
FinnGen @finngen.bsky.social · 29/01/2026
This week, Aarno Palotie and Mark Daly are visiting our Finnish partner organisations presenting what FinnGen has achieved and discussing how to develop it in the future. Great that the seminars, organised with help from the analysts that support FinnGen locally, have turned out to be popular!
Mark Daly presenting in a full lecture room.
021
FinnGen @finngen.bsky.social · 29/01/2026
We've been contributing to an international study identifying 13 genetic markers associated with infection with the Omicron variant of the coronavirus. The study, led by Statens Serum Institut, was recently published in Nature Genetics: 🔗 www.nature.com/articles/s41... 🔗 en.ssi.dk/news/news/20...
en.ssi.dk
New study finds distinct genetic risk factors for infection with the Omicron variant of the coronavirus
Genetic differences may influence the risk of infection with the highly transmissible Omicron variant, and the patterns differ from earlier coronavirus variants, according to a new large international...
020
Reposted by FinnGen
Andrea Ganna @andganna.bsky.social · 29/12/2025
New preprint 👇 Does diagnostic misclassification in EHR-based psychiatry GWAS suppress genetic discovery? We use simulations and FinnGen data to expand the SuperControl framework and propose a new ML approach (PRISMA) to boost signal discovery. Led by Lisa Eick & Zhiyu Yang!
1236
FinnGen @finngen.bsky.social · 22/12/2025
On behalf of all of us in FinnGen team, we wish you Happy Holidays and a wonderful New Year full of exciting scientific discoveries! Thank you for being part of the FinnGen community and for helping move this effort forward together. 🧬❄️
Season’s Greetings card with a blue background and festive starbursts, featuring a Helsinki city skyline stylized to resemble a Manhattan plot. Text reads: ‘Season’s Greetings. Wishing you a happy holiday season, and many thanks for a great year together!’ The FinnGen logo appears above the skyline.”
040
FinnGen @finngen.bsky.social · 22/12/2025
Kindly note that the URLs for our publicly available meta-analysis result browsers have been updated. The browsers are now accessible at: ➡️FinnGen + pan-UKBB meta-analysis results: public-metaresults-fg-ukbb.finngen.fi ➡️FinnGen-MVP-UKBB meta-analysis results: public-mvp-ukbb.finngen.fi
030
FinnGen @finngen.bsky.social · 19/12/2025
Autumn semester publication wrap-up! 📄 This autumn, FinnGen researchers contributed to a remarkable set of papers across human genetics, medicine, and methods; spanning @natgenet.nature.com, @natcomms.nature.com, Hypertension, @ajhgnews.bsky.social and more. Here’s a 🧵 highlighting these studies ⬇️
132
FinnGen @finngen.bsky.social · 10/12/2025
We are looking for a Software Developer to join our international team in Finland! With us, you will gain invaluable experience in high-impact software solutions that empower researchers to analyse and visualise extensive genomic and health data. Apply by 30 Jan: jobs.helsinki.fi/job/Helsinki...
A recruitment graphic for the FinnGen project. On the left is the FinnGen logo, featuring a stylized DNA helix in grey and blue with the word “FINNGEN” beneath it. On the right, bold black text reads “SOFTWARE DEVELOPER” and below it “FOR THE FINNGEN PROJECT.” Under that are the logos of FIMM (Institute for Molecular Medicine Finland, HiLIFE Unit) and the University of Helsinki. At the bottom, large text says “APPLY BY 30 JAN.”
031
Reposted by FinnGen
Masahiro Kanai @masakanai.bsky.social · 01/12/2025
Excited to share our new FinnGen single-nucleus multiome preprint! 🧬 We profiled ~10M PBMCs (snRNA-seq + snATAC-seq) from 1,108 Finnish donors to map how genetic variants drive complex disease through chromatin and gene regulation 🧵👇 🔗 Link: www.medrxiv.org/content/10.1...
13318
FinnGen @finngen.bsky.social · 27/11/2025
Researchers from the University of Edinburgh carried out the largest genetic analysis of delirium to date, drawing on data from several study cohorts, including FinnGen. The results demonstrate that APOE contributes to delirium susceptibility independently of dementia. www.ed.ac.uk/news/study-f...
ed.ac.uk
Study finds gene linked with risk of delirium | News | The University of Edinburgh
A major genetic risk factor for delirium has been identified in a landmark study that analysed the DNA of more than one million people worldwide.
130
FinnGen @finngen.bsky.social · 26/11/2025
In a new study, @hheyne.bsky.social and her team identified a Finnish-enriched missense variant in the SCN5A gene that acts like a natural lifelong cardiac sodium channel blockade, decreasing the risk of cardiac arrhythmias while also having some negative effects. hpi.de/en/article/h...
hpi.de
HPI study finds advances in the treatment of heart disease
HPI researchers Dr. Henrike Heyne, Julian Wanner and their team discover gene variant that acts like heart medication. Their study has now been published.
151
Reposted by FinnGen
Henrike Heyne @hheyne.bsky.social · 24/11/2025
Check out our new article in #Circulation on an astonishing genetic variant in the ion channel #SCN5A that enables us to learn about #cardiac-arrhythmia and their treatment with sodium channel blockers. @finngen.bsky.social www.ahajournals.org/doi/10.1161/... Congrats to @jwanner.bsky.social
ahajournals.org
Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade | Circulation
BACKGROUND: Atrial fibrillation and other cardiac arrhythmias pose a major public health burden, but prevention remains difficult. We investigated a genetic variant that we found to act like a natural...
153
FinnGen @finngen.bsky.social · 20/11/2025
Depression in young adulthood has a stronger hereditary component and is associated with a higher risk of suicide attempts than depression that begins later in life, according to a new study led by researchers @ki.se, including FinnGen as one of the study cohorts: news.ki.se/genes-may-pr...
news.ki.se
Genes may predict suicide risk in depression
Depression in young adulthood has a stronger hereditary component and is associated with a higher risk of suicide attempts than depression that begins later in life, according to a new study published...
120
FinnGen @finngen.bsky.social · 12/11/2025
We are proud to welcome Alnylam Pharmaceuticals as the 15th pharma company to join our public-private partnership! Alnylam brings world-leading expertise in RNAi therapeutics to the consortium, further enriching the scientific and translational potential of the study. www.finngen.fi/en/alnylam-b...
finngen.fi
Alnylam Becomes Newest Partner in FinnGen Consortium | FinnGen
FinnGen is proud to welcome Alnylam Pharmaceuticals as its newest industry partner. As the 15th pharmaceutical company to join the public-private partnership, Alnylam brings world-leading expertise in...
041
FinnGen @finngen.bsky.social · 31/10/2025
FinnGen-aineistoa hyödyntänyt LL Joel Räsäsen normaalipaineisen hydrokefalian eli NPH-taudin geneettistä taustaa käsittelevä väitöskirja tarkastetaan tänään Itä-Suomen yliopiston terveystieteiden tiedekunnassa Kuopion kampuksella. Tilaisuutta voi seurata myös verkossa: www.uef.fi/fi/artikkeli...
uef.fi
LL Joel Räsänen, väitös 31.10.2025: Uusi tieto NPH-taudin geneettisestä taustasta voi auttaa valottamaan taudin syntymekanismeja
NPH-taudin genominlaajuinen tutkimus on ensimmäinen laatuaan maailmassa ja sen tulokset tarjoavat merkittävästi uutta tietoa taudin geneettisistä tekijöistä.
010
Reposted by FinnGen
Nature Reviews Cancer @natrevcancer.nature.com · 20/10/2025
Comment🚨 Large biobank projects like #FinnGen help in uncovering genetic factors that influence cancer risk and outcomes, enhancing risk prediction & biomarker and drug target discovery. @finngen.bsky.social @dalygene.bsky.social @aoxing2.bsky.social 📖 👇
bit.ly
Unlocking the potential of FinnGen to advance cancer research - Nature Reviews Cancer
Large biobank projects such as FinnGen have enabled systematic searches for inherited factors that causally influence a wide range of human traits, including cancer risk and outcome. These explorations provide genetic insights for various aspects of cancer research, including improved risk prediction, enhanced biomarker and drug target discovery, and personalized medicine.
063
FinnGen @finngen.bsky.social · 20/10/2025
If you are in or around Turku tomorrow, don’t miss Prof. Mark Daly’s @biocityturku.bsky.social guest seminar highlighting the latest FinnGen discoveries! 📆21st Oct at 12:00-13:00, Presidentti auditorium, BioCity Title: FinnGen and the road ahead in human genetics 🔗 biocityturku.fi/events/bioci...
Mark Daly stands smiling with arms crossed against a white background featuring light green abstract biological shapes. The logo “BioCity Turku” appears near the bottom left.
050
FinnGen @finngen.bsky.social · 17/10/2025
Day 4 at #ASHG2025 and the FinnGen team is still going strong! 💪🧬 Visit today’s FinnGen posters (see the thread) and swing by booth #147 for some Finnish candies and great conversation!
100
Reposted by FinnGen
Aoxing Liu @aoxing2.bsky.social · 16/10/2025
Excited (😁) to share a commentary on @finngen.bsky.social & cancer research, co-written with Mervi Aavikko & @dalygene.bsky.social!! (View-only full text -> rdcu.be/eLlJs)
171
FinnGen @finngen.bsky.social · 16/10/2025
So much great FinnGen science on display again today at #ASHG2025! Make sure to visit the posters listed here, and stop by at our booth (# 147) for some Finnish salmiakki!
110
FinnGen @finngen.bsky.social · 15/10/2025
Here’s a look at today’s FinnGen-related posters at #ASHG25, showcasing some of our research community's latest discoveries.
121
FinnGen @finngen.bsky.social · 15/10/2025
#ASHG2025 in Boston is off to a great start! The FinnGen team is ready and waiting for you at Booth #147! Come say hi, explore insights from one of the world’s largest genomics initiatives and grab a FinnGen canvas bag (and other goodies)!
Two representatives at the FinnGen booth at the ASHG conference, standing behind a white counter with the FinnGen logo. The booth displays banners and screens in the background, and several navy-blue FinnGen canvas bags are visible on the side.
030
FinnGen @finngen.bsky.social · 14/10/2025
Just in time for #ASHG2025, a new FinnGen public data release is live! This release features the first clinical laboratory value association results. Analyses cover 383 lab measurements (OMOPIDs) with data from ≥1,000 participants each. Access the results here: www.finngen.fi/en/access_re...
FinnGen public release October 14: The first set of clinical laboratory value GWAS results. FinnGen logo and a black-and-white abstract genetic data pattern at the bottom. Graphics credits: Aalto University, Visual Communication Design Team.
1198
FinnGen @finngen.bsky.social · 10/10/2025
We’re getting ready for an exciting week at #ASHG2025 in Boston! Come meet the FinnGen team at booth 147 - we’ll be sharing updates and showcasing new public resources and tools. Plus, don’t miss the various presentations featuring FinnGen results across the program! www.finngen.fi/en/meet-finn...
finngen.fi
Meet FinnGen at the ASHG 2025! | FinnGen
Results based on the FinnGen data are presented in almost 40 talks or posters during the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) in Boston, October 14-18. We also have a b...
043
Reposted by FinnGen
Andrea Ganna @andganna.bsky.social · 08/10/2025
💥 New preprint & our first RCT! 💥 Does an extremely high or low BMI polygenic score influence weight loss after a diet intervention? GENEROOS is a 6-month randomized diet vs. control trial testing if genetic predisposition to higher BMI affects weight loss in overweight adults
2287
FinnGen @finngen.bsky.social · 12/09/2025
FinnGen is in the spotlight! In EP 204 of #TheGeneticsPodcast, Prof. @sripatti.bsky.social, director of @fimm-uh.bsky.social, discusses how FinnGen’s data are helping translate genetics into real-world clinical tools, such as polygenic risk scores & treatment prediction. 🎙️ pod.fo/e/328c49
Podcast cover image for The Genetics Podcast Episode 204. The background is orange with faint letters A, C, T, G. On the right is a portrait of Samuli Ripatti wearing glasses and a suit. The title text reads: 'Bringing cardiovascular genetics and biobank discoveries into the clinic.' Below: 'With Samuli Ripatti of the University of Helsinki.' A label in the bottom right corner shows 'Ep 204'.
033
FinnGen @finngen.bsky.social · 05/09/2025
This week, ~230 national and international FinnGen partner researchers came together in Helsinki for our annual F2F-meeting at Kalastajatorppa. The excellent scientific presentations and exchange of ideas will help shape the next phase of FinnGen and advance our scientific goals. Thank you!
A group photo of the meeting participants raising their glasses.
042
FinnGen @finngen.bsky.social · 03/09/2025
Congratulations to the winners of the FinnGen Publication Prize 2025! 🎉 🏆 Jakob German (FIMM/UH) 🏆 Ville Salo (University of Oulu) This annual prize is announced during our F2F meeting, celebrating outstanding science from the past year. A big thank you to Scellex for sponsoring this year’s prize!
Blue background with confetti and the title “FinnGen Prize for the Best Papers 2025.” On the left, a photo of Jakob German (FIMM/UH) above the title and journal reference: Nature Medicine, June 2025, with the paper title: Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design. On the right, a photo of Ville Salo (University of Oulu) above the title and journal reference: Nature Communications, Nov 2024, with the paper title: Genome-wide meta-analysis conducted in three large biobanks expands the genetic landscape of lumbar disc herniations. The center features the FinnGen logo and text “The prize is sponsored by Scellex – single cell solutions.”
060
FinnGen @finngen.bsky.social · 03/09/2025
It's the FinnGen Helsinki F2F time of the year! Our Scientific Director Aarno Palotie just kicked off this year's meeting by warmly welcoming our international and local guests. The next two days will be all about exciting science, great discussions, and catching up with colleagues.
Aarno Palotie presenting, with a slide showing the timeline of the FinnGen project.
040
Reposted by FinnGen
Aoxing Liu @aoxing2.bsky.social · 21/08/2025
Our trisomy work is now online! 🚀 Got curious after reading our short PheWAS paper? 👀 Catch me 🌠 & my talk 🎤 this October at #ASHG25 in Boston! Yes, I am still endlessly curious about sex chromosome aneuploidies - whether it's somatic (X/Y loss) or germline (trisomies)!! 💘
1162
Reposted by FinnGen
The American Journal of Human Genetics @ajhgnews.bsky.social · 20/08/2025
📣Online now! 📄 #PheWAS of male and female sex chromosome trisomies in 1.5 million participants of MVP, FinnGen, and UK Biobank @finngen.bsky.social @ukbiobank.bsky.social
cell.com
Phenome-wide association study of male and female sex chromosome trisomies in 1.5 million participants of MVP, FinnGen, and UK Biobank
We examined disease associations for sex chromosome trisomies (SCTs) by performing a phenome-wide association study in 2,769 individuals with SCT (47,XXY: 1,319; 47,XYY: 1,108; and 47,XXX: 342). Many ...
083
FinnGen @finngen.bsky.social · 21/08/2025
We are looking for a Data Scientist to support our clinically oriented research teams in generating insights from decades of rich, longitudinal health data. If you are inspired by the opportunity to contribute to cutting-edge research at a global scale, apply here: jobs.helsinki.fi/job/Helsinki...
Recruitment banner for a Data Scientist position for the FinnGen project. Left: Large FinnGen logo. Right: Black text reads ‘DATA SCIENTIST for the FinnGen project.’ Below are the logos of FIMM and University of Helsinki. Bold black text at the bottom reads ‘APPLY BY 14 SEP.
063
FinnGen @finngen.bsky.social · 18/08/2025
📢 Another month, another set of impactful studies! Here are the papers published in July 2025 that utilized FinnGen data and credited us as a co-author. Exciting to see our resource advancing science across medical fields. Thread👇 #FinnGen #genetics
130
FinnGen @finngen.bsky.social · 06/08/2025
A new FinnGen-based study by researchers from Tampere University & @ki.se has identified genetic variants linked to brain function, immune defence and metabolism that contribute to the development of frailty in older people. #genomics #research news.ki.se/genes-reveal...
news.ki.se
Genes reveal why some older people suffer from frailty
A new study has identified genetic variants linked to brain function, immune defence and metabolism that contribute to the development of frailty in older people. The study, published in Nature Aging ...
142